Madam Speaker, I thank the hon. member for introducing the motion today. I would like to ask him a question about his question, which is why scientists like to ask the question “Why?”. It is on the issue of drug shortages.
In the United States, the Senate passed Bill S.3187, in which they decided to study the correlations between drug shortages and factors such as the number of manufacturers, the pricing structure and the contracting practices, while here in Canada we seem to be content to simply set up a website where people can track what drugs are in shortage and we do not seem to be interested in thinking about and investigating the root cause.
I would ask my hon. colleague to comment on the government's performance on this issue with regard to asking the question of why.